When Should You SELL Your Stocks (8 Reasons to Sell Your Stocks) Click to watch on Youtube.

Fate Therapeutics Stock Forecast

NASDAQ:FATE BUY

$33.42 (2.67%)

Volume: 1.16M

Closed: Aug 05, 2022

Hollow Logo Score: 5.137

Fate Therapeutics Stock Forecast

BUY NASDAQ:FATE
$33.42 (2.67%)

Volume: 1.16M

Closed: Aug 05, 2022

Score Hollow Logo 5.137

FATE Price Targets and Analyst Ratings NASDAQ:FATE

FATE Forecast. What You Should Know.

FATE Historical Ratings and Targets

Unlock All Premium Features! Go Premium! Only $19.90/Month

Unlock the Top 5 candidates in every list
Unlock full Ultimate List Builder
Golden Star lists & Auto Portfolios
Possible Runners & Moving Average lists
Ad-free browsing
Save data in PDF

About Fate Therapeutics

Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell lymphoma and chronic lymphocytic leukemia; FT538 to treat AML and multiple myeloma; FT576 to treat mul... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT